225 related articles for article (PubMed ID: 36287138)
21. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
22. Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients.
You J; Zhang H; Shen Y; Chen C; Liu W; Zheng M; Van Poucke S; Guo G; Huang Z
Onco Targets Ther; 2017; 10():2199-2208. PubMed ID: 28458563
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis.
Reudink M; Slooter CD; Janssen L; Lieverse AG; Roumen RMH; Slooter GD
Ann Med Surg (Lond); 2021 Nov; 71():102997. PubMed ID: 34840752
[TBL] [Abstract][Full Text] [Related]
24. The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.
Liu T; Fan Y; Zhang Q; Wang Y; Yao N; Song M; Zhang Q; Cao L; Song C; Shi H
Inflamm Res; 2022 Aug; 71(7-8):899-909. PubMed ID: 35715516
[TBL] [Abstract][Full Text] [Related]
25. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Chen G; Liang B; Zhang H; Ji K; Huang J; Lin J; Zheng X; Niu W
Int J Cancer; 2016 Dec; 139(12):2705-2713. PubMed ID: 27560834
[TBL] [Abstract][Full Text] [Related]
26. The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.
Harlid S; Myte R; Van Guelpen B
Mediators Inflamm; 2017; 2017():4803156. PubMed ID: 28522899
[TBL] [Abstract][Full Text] [Related]
27. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao P; Xia N; Zhang H; Deng T
Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
[TBL] [Abstract][Full Text] [Related]
28. The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer.
Reed M; Patrick C; Croft B; Walde N; Voutsadakis IA
Indian J Gastroenterol; 2019 Feb; 38(1):15-22. PubMed ID: 30701442
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study.
Ulaganathan V; Kandiah M; Zalilah MS; Faizal JA; Fijeraid H; Normayah K; Gooi BH; Othman R
Asian Pac J Cancer Prev; 2012; 13(8):3873-7. PubMed ID: 23098486
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Syndrome Components and the Risk of Colorectal Cancer: A Population-Based Prospective Study in Chinese Men.
Li X; Chen H; Wang G; Feng X; Lyu Z; Wei L; Wen Y; Chen S; Wu S; Hang D; Dai M; Li N; He J
Front Oncol; 2019; 9():1047. PubMed ID: 31681585
[No Abstract] [Full Text] [Related]
31. Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis.
Petrelli F; Ghidini M; Rausa E; Ghidini A; Cabiddu M; Borgonovo K; Ghilardi M; Parati MC; Pietrantonio F; Sganzerla P; Bossi AC
Can J Diabetes; 2021 Mar; 45(2):186-197.e2. PubMed ID: 33039329
[TBL] [Abstract][Full Text] [Related]
32. Association of modifiable lifestyle with colorectal cancer incidence and mortality according to metabolic status: prospective cohort study.
Xie P; Wu S; Kuo Z; Tian H; He Q; Li Y; Mi N; Hu L; Zhao H; Li W; Xia B; Yuan J; Yang K; Zhang C; He Y
Front Oncol; 2023; 13():1162221. PubMed ID: 37324025
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations.
Zheng Y; Xie Z; Li J; Chen C; Cai W; Dong Y; Xue R; Liu C
BMC Cardiovasc Disord; 2021 Feb; 21(1):90. PubMed ID: 33588759
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis.
Zuin M; Roncon L; Passaro A; Cervellati C; Zuliani G
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2244-2252. PubMed ID: 34039508
[TBL] [Abstract][Full Text] [Related]
35. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
Xu P; Wang J
J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
[No Abstract] [Full Text] [Related]
36. Alteration of Metabolic Syndrome Is Associated with the Decreased Risk of Colorectal Cancer.
Jin EH; Choi YJ; Lim JH; Shin CM; Han K; Lee DH
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568291
[TBL] [Abstract][Full Text] [Related]
37. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
38. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
[TBL] [Abstract][Full Text] [Related]
39. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
40. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis.
Boakye D; Rillmann B; Walter V; Jansen L; Hoffmeister M; Brenner H
Cancer Treat Rev; 2018 Mar; 64():30-39. PubMed ID: 29459248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
